Elisabeth Livingstone

University Hospital Essen

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Collaborators (12)

Ralf Gutzmer

Ruhr-Universität Bochum

Selma Ugurel

Angela Krackhardt

Technical University of Munich

Jeovanis Gil

Klaus Griewank

Bastian Schilling

Associate Professor

Universitätsklinikum Würzburg

Markus V Heppt

Universitätsklinikum Erlangen

Julia Huynh

Charité - Universitätsmedizin Berlin

Dirk Schadendorf

University Hospital Essen

Clemens Aigner

Professor of Thoracic Surgery

Medical University of Vienna

Alexander Kreuter

Cyrill Géraud

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Elisabeth Livingstone

Research Interests

Explore related searches

Contact this professor

Articles (20)

Collaborators (12)

Ralf Gutzmer

Selma Ugurel

Angela Krackhardt

Jeovanis Gil

Klaus Griewank

Bastian Schilling

Markus V Heppt

Julia Huynh

Dirk Schadendorf

Clemens Aigner

Alexander Kreuter

Cyrill Géraud

Make your next move.

Elisabeth Livingstone

Research Interests

Explore related searches

Contact this professor

Articles (20)

The Mappability of Clinical Real-World Data of Patients with Melanoma to Oncological Fast Healthcare Interoperability Resources (FHIR) Profiles: A Single-Center Interoperability Study

A Systematic Comparison of Task Adaptation Techniques for Digital Histopathology

Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanoma

Association of antibiotic treatment with survival outcomes in treatment-naïve melanoma patients receiving immune checkpoint blockade

Case report: Durable complete response of a mucosal melanoma of the rectum after neoadjuvant immunotherapy with ipilimumab plus nivolumab

Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma

Drug-related exanthema under immunotherapy and targeted oncological therapy,Arzneimittelexantheme unter Immun- und zielgerichteter onkologischer Therapie

Health-related quality of life and its influencing factors in patients with primary cutaneous B-cell lymphomas: A multicentric study in 100 patients

Preferences of physicians for treatment-related toxicity vs. recurrence in melanoma (GERMELATOX-A): the doctors’ perspective

The RANKL inhibitor denosumab in combination with dual checkpoint inhibition is associated with increased CXCL-13 serum concentrations

Adjuvant treatment and outcome of stage III melanoma patients: Results of a multicenter real-world DeCOG study

COMBI-r: A Prospective, Non-Interventional Study of Dabrafenib Plus Trametinib in Unselected Patients with Unresectable or Metastatic BRAF V600-Mutant Melanoma

Genetic and Methylation Analysis of CTNNB1 in Benign and Malignant Melanocytic Lesions

Validating Automatic Concept-Based Explanations for AI-Based Digital Histopathology

Genetic and Clinical Characteristics of <i>ARID1A</i> Mutated Melanoma Reveal High Tumor Mutational Load without Implications on Patient Survival

The Prognostic Relevance of PMCA4 Expression in Melanoma: Gender Specificity and Implications for Immune Checkpoint Inhibition

Factors Influencing the Adjuvant Therapy Decision: Results of a Real-World Multicenter Data Analysis of 904 Melanoma Patients

Encorafenib, binimetinib plus pembrolizumab triplet therapy in patients with advanced BRAFV600 mutant melanoma: safety and tolerability results from the phase I IMMU-TARGET trial

Computed tomography-guided biopsy of radiologically unclear lesions in advanced skin cancer: A retrospective analysis of 47 cases

Discontinuation of BRAF/MEK-Directed Targeted Therapy after Complete Remission of Metastatic Melanoma—A Retrospective Multicenter ADOReg Study

Collaborators (12)

Ralf Gutzmer

Selma Ugurel

Angela Krackhardt

Jeovanis Gil

Klaus Griewank

Bastian Schilling

Markus V Heppt

Julia Huynh

Dirk Schadendorf

Clemens Aigner

Alexander Kreuter

Cyrill Géraud

Make your next move.